The Oncology Institute, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 147.4M | 142.0M | 136.6M | 119.8M | 104.4M | 100.3M | 99.9M | 98.6M |
| Cost of Goods Sold | 125.7M | 119.2M | 117.6M | 102.3M | 87.2M | 85.6M | 85.5M | 85.6M |
| Gross Profit | 21.7M | 22.8M | 18.9M | 17.5M | 17.2M | 14.6M | 14.4M | 13.0M |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 28.2M | 29.7M | 27.0M | 28.7M | 27.2M | 26.6M | 28.2M | 29.4M |
| Operating Income | -6.5M | -6.9M | -8.1M | -11.2M | -9.9M | -11.9M | -13.9M | -16.4M |
| Other Income / Gains | 4.0M | -601K | -8.4M | -5.9M | -9.7M | -1.3M | -2.3M | 885K |
| Net Income | -2.5M | -7.5M | -16.5M | -17.0M | -19.6M | -13.2M | -16.1M | -15.5M |
| EPS (Diluted) | -0.02 | -0.04 | -0.14 | -0.15 | -0.21 | -0.14 | -0.18 | -0.17 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.147 | 0.16 | 0.139 | 0.146 | 0.165 | 0.146 | 0.144 | 0.132 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 28.2M | 28.0M | 25.3M | 0 | 25.4M | 24.9M | 0 | 0 |
| Other Expenses | 0 | 1.6M | 1.7M | 28.7M | 1.8M | 1.7M | 28.2M | 29.4M |
| Cost And Expenses | 154.0M | 148.9M | 144.6M | 131.0M | 114.3M | 112.2M | 113.8M | 114.9M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.9M | 1.9M | 1.9M | 1.9M | 5.6M | 1.2M | 2.2M | 2.1M |
| Depreciation And Amortization | 1.6M | 1.6M | 1.7M | 1.8M | 1.8M | 1.7M | 1.6M | 1.5M |
| Ebitda | 1.1M | -4.0M | -12.9M | -13.5M | -12.2M | -10.3M | -12.3M | -11.8M |
| Ebitdaratio | 0.007 | -0.028 | -0.094 | -0.112 | -0.117 | -0.103 | -0.123 | -0.12 |
| Operating Income Ratio | -0.044 | -0.049 | -0.059 | -0.094 | -0.095 | -0.119 | -0.139 | -0.166 |
| Income Before Tax | -2.5M | -7.5M | -16.5M | -17.1M | -19.6M | -13.2M | -16.1M | -15.5M |
| Income Before Tax Ratio | -0.017 | -0.053 | -0.121 | -0.143 | -0.188 | -0.131 | -0.161 | -0.157 |
| Income Tax Expense | 0 | 0 | 0 | -131K | 0 | 0 | 0 | 0 |
| Net Income Ratio | -0.017 | -0.053 | -0.121 | -0.142 | -0.188 | -0.131 | -0.161 | -0.157 |
| Epsdiluted | -0.02 | -0.04 | -0.14 | -0.15 | -0.21 | -0.14 | -0.18 | -0.17 |
| Weighted Average Shs Out | 1.02B | 1.01B | 974.7M | 932.0M | 77.1M | 75.7M | 75.5M | 74.7M |
| Weighted Average Shs Out Dil | 1.02B | 1.01B | 974.7M | 932.0M | 77.1M | 75.7M | 75.5M | 74.7M |